Download PDF
Semin Thromb Hemost 2021; 47(05): 610-620
DOI: 10.1055/s-0041-1725095
Review Article

Fibrinolysis and Remote Ischemic Conditioning: Mechanisms and Treatment Perspectives in Stroke

Andreas Engel Krag
1   Thrombosis and Hemostasis Research Unit, Aarhus University Hospital, Aarhus, Denmark
,
Rolf Ankerlund Blauenfeldt
2   Department of Neurology, Danish Stroke Center, Aarhus University Hospital, Aarhus, Denmark
3   Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Stroke is a leading cause of death and disability. Intravenous thrombolysis and mechanical thrombectomy have greatly improved outcomes in acute ischemic stroke (AIS). However, only a minority of patients receive reperfusion therapies, highlighting the need for novel neuroprotective therapies. Remote ischemic conditioning (RIC), consisting of brief, intermittent extremity occlusion and reperfusion induced with an inflatable cuff, is a potential neuroprotective therapy in acute stroke. The objective of this narrative review is to describe the effect of RIC on endogenous fibrinolysis and, from this perspective, investigate the potential of RIC in the prevention and treatment of stroke. A systematic literature search was performed in PubMed, and human studies in English were included. Seven studies had investigated the effect of RIC on fibrinolysis in humans. Long-term daily administration of RIC increased endogenous fibrinolysis, whereas a single RIC treatment did not acutely influence endogenous fibrinolysis. Fifteen studies had investigated the effect of RIC as a neuroprotective therapy in the prevention and treatment of stroke. Long-term RIC administration proved effective in reducing new cerebral vascular lesions in patients with established cerebrovascular disease. In patients with acute stroke, RIC was safe and feasible, though its clinical efficacy as a neuroprotectant is yet unproven. In conclusion, a single RIC treatment does not affect fibrinolysis in the acute phase, whereas long-term RIC administration may increase endogenous fibrinolysis. Increased endogenous fibrinolysis is unlikely to be the mediator of the acute neuroprotective effect of RIC in stroke patients, whereas it may partly explain the reduced stroke recurrence associated with long-term RIC treatment.

Keywords

fibrinolysis - ischemic preconditioning - stroke - cerebral hemorrhage - intracranial arteriosclerosis


Publication History

Article published online:
20 April 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74 (05) 1124-1136
    CrossrefPubMedGoogle Scholar
  • 2 Kharbanda RK, Mortensen UM, White PA. et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 2002; 106 (23) 2881-2883
    CrossrefPubMedGoogle Scholar
  • 3 Bøtker HE, Kharbanda R, Schmidt MR. et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 2010; 375 (9716): 727-734
    CrossrefPubMedGoogle Scholar
  • 4 Hougaard KD, Hjort N, Zeidler D. et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke 2014; 45 (01) 159-167
    CrossrefPubMedGoogle Scholar
  • 5 Hoda MN, Bhatia K, Hafez SS. et al. Remote ischemic perconditioning is effective after embolic stroke in ovariectomized female mice. Transl Stroke Res 2014; 5 (04) 484-490
    CrossrefPubMedGoogle Scholar
  • 6 Lim SY, Hausenloy DJ. Remote ischemic conditioning: from bench to bedside. Front Physiol 2012; 3: 27
    PubMedGoogle Scholar
  • 7 Hess DC, Blauenfeldt RA, Andersen G. et al. Remote ischaemic conditioning-a new paradigm of self-protection in the brain. Nat Rev Neurol 2015; 11 (12) 698-710
    CrossrefPubMedGoogle Scholar
  • 8 Ma J, Ma Y, Dong B, Bandet MV, Shuaib A, Winship IR. Prevention of the collapse of pial collaterals by remote ischemic perconditioning during acute ischemic stroke. J Cereb Blood Flow Metab 2017; 37 (08) 3001-3014
    CrossrefPubMedGoogle Scholar
  • 9 Kitagawa K, Saitoh M, Ishizuka K, Shimizu S. Remote limb ischemic conditioning during cerebral ischemia reduces infarct size through enhanced collateral circulation in murine focal cerebral ischemia. J Stroke Cerebrovasc Dis 2018; 27 (04) 831-838
    CrossrefPubMedGoogle Scholar
  • 10 Ma J, Ma Y, Shuaib A, Winship IR. Improved collateral flow and reduced damage after remote ischemic perconditioning during distal middle cerebral artery occlusion in aged rats. Sci Rep 2020; 10 (01) 12392
    CrossrefPubMedGoogle Scholar
  • 11 Thompson JW, Dave KR, Young JI, Perez-Pinzon MA. Ischemic preconditioning alters the epigenetic profile of the brain from ischemic intolerance to ischemic tolerance. Neurotherapeutics 2013; 10 (04) 789-797
    CrossrefPubMedGoogle Scholar
  • 12 Li J, Hu XS, Zhou FF. et al. Limb remote ischemic postconditioning protects integrity of the blood-brain barrier after stroke. Neural Regen Res 2018; 13 (09) 1585-1593
    CrossrefPubMedGoogle Scholar
  • 13 Stenzel-Poore MP, Stevens SL, Xiong Z. et al. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 2003; 362 (9389): 1028-1037
    CrossrefPubMedGoogle Scholar
  • 14 Vaibhav K, Braun M, Khan MB. et al. Remote ischemic post-conditioning promotes hematoma resolution via AMPK-dependent immune regulation. J Exp Med 2018; 215 (10) 2636-2654
    CrossrefPubMedGoogle Scholar
  • 15 Hausenloy DJ, Iliodromitis EK, Andreadou I. et al. Investigating the signal transduction pathways underlying remote ischemic conditioning in the porcine heart. Cardiovasc Drugs Ther 2012; 26 (02) 87-93
    CrossrefPubMedGoogle Scholar
  • 16 Lecour S. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway?. J Mol Cell Cardiol 2009; 47 (01) 32-40
    CrossrefPubMedGoogle Scholar
  • 17 Ren C, Li N, Li S. et al. Limb ischemic conditioning improved cognitive deficits via eNOS-dependent augmentation of angiogenesis after chronic cerebral hypoperfusion in rats. Aging Dis 2018; 9 (05) 869-879
    CrossrefPubMedGoogle Scholar
  • 18 Warzecha Z, Dembiński A, Ceranowicz P. et al. Influence of ischemic preconditioning on blood coagulation, fibrinolytic activity and pancreatic repair in the course of caerulein-induced acute pancreatitis in rats. J Physiol Pharmacol 2007; 58 (02) 303-319
    PubMedGoogle Scholar
  • 19 Meng R, Ding Y, Asmaro K. et al. Ischemic conditioning is safe and effective for octo- and nonagenarians in stroke prevention and treatment. Neurotherapeutics 2015; 12 (03) 667-677
    CrossrefPubMedGoogle Scholar
  • 20 Pryds K, Kristiansen J, Neergaard-Petersen S. et al. Effect of long-term remote ischaemic conditioning on platelet function and fibrinolysis in patients with chronic ischaemic heart failure. Thromb Res 2017; 153: 40-46
    CrossrefPubMedGoogle Scholar
  • 21 Krag AE, Hvas AM. Ischemic conditioning as a hemostatic intervention in surgery and cardiac procedures: a systematic review. Semin Thromb Hemost 2017; 43 (07) 716-731
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Hoffman M, Monroe III DM. A cell-based model of hemostasis. Thromb Haemost 2001; 85 (06) 958-965
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Emiru T, Bershad EM, Zantek ND. et al. Intracerebral hemorrhage: a review of coagulation function. Clin Appl Thromb Hemost 2013; 19 (06) 652-662
    CrossrefPubMedGoogle Scholar
  • 24 Powers WJ, Rabinstein AA, Ackerson T. et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2019; 50 (12) e344-e418
    CrossrefPubMedGoogle Scholar
  • 25 Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 1981; 12 (06) 723-725
    CrossrefPubMedGoogle Scholar
  • 26 Ramos-Cabrer P, Campos F, Sobrino T, Castillo J. Targeting the ischemic penumbra. Stroke 2011; 42 (1, Suppl): S7-S11
    CrossrefPubMedGoogle Scholar
  • 27 Saver JL. Time is brain--quantified. Stroke 2006; 37 (01) 263-266
    CrossrefPubMedGoogle Scholar
  • 28 Berkhemer OA, Fransen PSS, Beumer D. et al; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372 (01) 11-20
    CrossrefPubMedGoogle Scholar
  • 29 National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333 (24) 1581-1587
    CrossrefPubMedGoogle Scholar
  • 30 Thomalla G, Simonsen CZ, Boutitie F. et al; WAKE-UP Investigators. MRI-Guided thrombolysis for stroke with unknown time of onset. N Engl J Med 2018; 379 (07) 611-622
    CrossrefPubMedGoogle Scholar
  • 31 Nogueira RG, Jadhav AP, Haussen DC. et al; DAWN Trial Investigators. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018; 378 (01) 11-21
    CrossrefPubMedGoogle Scholar
  • 32 Albers GW, Marks MP, Kemp S. et al; DEFUSE 3 Investigators. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018; 378 (08) 708-718
    CrossrefPubMedGoogle Scholar
  • 33 Bouckaert M, Lemmens R, Thijs V. Reducing prehospital delay in acute stroke. Nat Rev Neurol 2009; 5 (09) 477-483
    CrossrefPubMedGoogle Scholar
  • 34 Fassbender K, Balucani C, Walter S, Levine SR, Haass A, Grotta J. Streamlining of prehospital stroke management: the golden hour. Lancet Neurol 2013; 12 (06) 585-596
    CrossrefPubMedGoogle Scholar
  • 35 Kellner CP, Connolly Jr ES. Neuroprotective strategies for intracerebral hemorrhage: trials and translation. Stroke 2010; 41 (10, Suppl): S99-S102
    CrossrefPubMedGoogle Scholar
  • 36 Shao Z, Tu S, Shao A. Pathophysiological mechanisms and potential therapeutic targets in intracerebral hemorrhage. Front Pharmacol 2019; 10: 1079
    CrossrefPubMedGoogle Scholar
  • 37 van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 2010; 9 (02) 167-176
    CrossrefPubMedGoogle Scholar
  • 38 Anderson CS, Heeley E, Huang Y. et al; INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013; 368 (25) 2355-2365
    CrossrefPubMedGoogle Scholar
  • 39 Savitz SI, Baron J-C, Yenari MA, Sanossian N, Fisher M. Reconsidering neuroprotection in the reperfusion era. Stroke 2017; 48 (12) 3413-3419
    CrossrefPubMedGoogle Scholar
  • 40 Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535
    CrossrefPubMedGoogle Scholar
  • 41 Xu Y, Qi M, Wang N. et al. The effect of remote ischemic conditioning on blood coagulation function and cerebral blood flow in patients with aneurysmal subarachnoid hemorrhage. Neurol Sci 2020; 41 (02) 335-340
    CrossrefPubMedGoogle Scholar
  • 42 Memtsoudis SG, Stundner O, Yoo D. et al. Does limb preconditioning reduce pain after total knee arthroplasty? A randomized, double-blind study. Clin Orthop Relat Res 2014; 472 (05) 1467-1474
    CrossrefPubMedGoogle Scholar
  • 43 Krag AE, Kiil BJ, Hvas CL, Hvas AM. Effect of remote ischemic preconditioning on hemostasis and fibrinolysis in head and neck cancer surgery: a randomized controlled trial. PLoS One 2019; 14 (07) e0219496
    CrossrefPubMedGoogle Scholar
  • 44 Pedersen CM, Barnes G, Schmidt MR. et al. Ischaemia-reperfusion injury impairs tissue plasminogen activator release in man. Eur Heart J 2012; 33 (15) 1920-1927
    CrossrefPubMedGoogle Scholar
  • 45 Kristiansen J, Grove EL, Rise N. et al. Effect of remote ischaemic conditioning on coagulation and fibrinolysis. Thromb Res 2016; 141: 129-135
    CrossrefPubMedGoogle Scholar
  • 46 Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol 2019; 18 (07) 684-696
    CrossrefPubMedGoogle Scholar
  • 47 Ihara M, Yamamoto Y. Emerging evidence for pathogenesis of sporadic cerebral small vessel disease. Stroke 2016; 47 (02) 554-560
    CrossrefPubMedGoogle Scholar
  • 48 Liao Z, Bu Y, Li M. et al. Remote ischemic conditioning improves cognition in patients with subcortical ischemic vascular dementia. BMC Neurol 2019; 19 (01) 206
    CrossrefPubMedGoogle Scholar
  • 49 Banerjee C, Chimowitz MI. Stroke caused by atherosclerosis of the major intracranial arteries. Circ Res 2017; 120 (03) 502-513
    CrossrefPubMedGoogle Scholar
  • 50 Ferguson GG, Eliasziw M, Barr HWK. et al. The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. Stroke 1999; 30 (09) 1751-1758
    CrossrefPubMedGoogle Scholar
  • 51 Cole TS, Mezher AW, Catapano JS. et al. Nationwide trends in carotid endarterectomy and carotid artery stenting in the post-CREST era. Stroke 2020; 51 (02) 579-587
    CrossrefPubMedGoogle Scholar
  • 52 Zhao W, Meng R, Ma C. et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof-of-concept, randomized controlled trial. Circulation 2017; 135 (14) 1325-1335
    CrossrefPubMedGoogle Scholar
  • 53 Chimowitz MI, Lynn MJ, Derdeyn CP. et al; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011; 365 (11) 993-1003
    CrossrefPubMedGoogle Scholar
  • 54 Hurford R, Wolters FJ, Li L, Lau KK, Küker W, Rothwell PM. Oxford Vascular Study Phenotyped Cohort. Prevalence, predictors, and prognosis of symptomatic intracranial stenosis in patients with transient ischaemic attack or minor stroke: a population-based cohort study. Lancet Neurol 2020; 19 (05) 413-421
    CrossrefPubMedGoogle Scholar
  • 55 Meng R, Asmaro K, Meng L. et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology 2012; 79 (18) 1853-1861
    CrossrefPubMedGoogle Scholar
  • 56 England TJ, Hedstrom A, O'Sullivan S. et al. RECAST (Remote Ischemic Conditioning After Stroke Trial): a pilot randomized placebo controlled phase II trial in acute ischemic stroke. Stroke 2017; 48 (05) 1412-1415
    CrossrefPubMedGoogle Scholar
  • 57 England TJ, Hedstrom A, O'Sullivan SE. et al. Remote Ischemic Conditioning After Stroke Trial 2: a phase IIb randomized controlled trial in hyperacute stroke. J Am Heart Assoc 2019; 8 (23) e013572
    CrossrefPubMedGoogle Scholar
  • 58 Pico F, Lapergue B, Ferrigno M. et al. Effect of in-hospital remote ischemic perconditioning on brain infarction growth and clinical outcomes in patients with acute ischemic stroke: the RESCUE BRAIN Randomized Clinical Trial. JAMA Neurol 2020; 77 (06) 725-734
    CrossrefPubMedGoogle Scholar
  • 59 Pico F, Rosso C, Meseguer E. et al. A multicenter, randomized trial on neuroprotection with remote ischemic per-conditioning during acute ischemic stroke: the REmote iSchemic Conditioning in acUtE BRAin INfarction study protocol. Int J Stroke 2016; 11 (08) 938-943
    CrossrefPubMedGoogle Scholar
  • 60 Che R, Zhao W, Ma Q. et al. rt-PA with remote ischemic postconditioning for acute ischemic stroke. Ann Clin Transl Neurol 2019; 6 (02) 364-372
    CrossrefPubMedGoogle Scholar
  • 61 Li Y, Liang K, Zhang L, Hu Y, Ge Y, Zhao J. Upper limb ischemic postconditioning as adjunct therapy in acute stroke patients: a randomized pilot. J Stroke Cerebrovasc Dis 2018; 27 (11) 3328-3335
    CrossrefPubMedGoogle Scholar
  • 62 He YD, Guo ZN, Qin C. et al. Remote ischemic conditioning combined with intravenous thrombolysis for acute ischemic stroke. Ann Clin Transl Neurol 2020; 7 (06) 972-979
    CrossrefPubMedGoogle Scholar
  • 63 Le Page S, Bejan-Angoulvant T, Angoulvant D, Prunier F. Remote ischemic conditioning and cardioprotection: a systematic review and meta-analysis of randomized clinical trials. Basic Res Cardiol 2015; 110 (02) 11
    CrossrefPubMedGoogle Scholar
  • 64 Battipaglia I, Scalone G, Milo M, Di Franco A, Lanza GA, Crea F. Upper arm intermittent ischaemia reduces exercise-related increase of platelet reactivity in patients with obstructive coronary artery disease. Heart 2011; 97 (16) 1298-1303
    CrossrefPubMedGoogle Scholar
  • 65 Lanza GA, Stazi A, Villano A. et al. Effect of remote ischemic preconditioning on platelet activation induced by coronary procedures. Am J Cardiol 2016; 117 (03) 359-365
    CrossrefPubMedGoogle Scholar
  • 66 Stazi A, Scalone G, Laurito M. et al. Effect of remote ischemic preconditioning on platelet activation and reactivity induced by ablation for atrial fibrillation. Circulation 2014; 129 (01) 11-17
    CrossrefPubMedGoogle Scholar
  • 67 Thiebaut AM, Gauberti M, Ali C. et al. The role of plasminogen activators in stroke treatment: fibrinolysis and beyond. Lancet Neurol 2018; 17 (12) 1121-1132
    CrossrefPubMedGoogle Scholar
  • 68 Su EJ, Fredriksson L, Schielke GP, Eriksson U, Lawrence DA. Tissue plasminogen activator-mediated PDGF signaling and neurovascular coupling in stroke. J Thromb Haemost 2009; 7 (Suppl. 01) 155-158
    CrossrefPubMedGoogle Scholar
  • 69 Pang PT, Teng HK, Zaitsev E. et al. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 2004; 306 (5695): 487-491
    CrossrefPubMedGoogle Scholar
  • 70 Nicole O, Docagne F, Ali C. et al. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 2001; 7 (01) 59-64
    CrossrefPubMedGoogle Scholar
  • 71 Kvistad CE, Novotny V, Kurz MW. et al. Safety and outcomes of tenecteplase in moderate and severe ischemic stroke. Stroke 2019; 50 (05) 1279-1281
    CrossrefPubMedGoogle Scholar
  • 72 Campbell BCV, Mitchell PJ, Churilov L. et al; EXTEND-IA TNK Part 2 investigators. Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke: The EXTEND-IA TNK Part 2 Randomized Clinical Trial. JAMA 2020; 323 (13) 1257-1265
    CrossrefPubMedGoogle Scholar
  • 73 Campbell BCV, Mitchell PJ, Churilov L. et al; EXTEND-IA TNK Investigators. Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med 2018; 378 (17) 1573-1582
    CrossrefPubMedGoogle Scholar
  • 74 Blauenfeldt RA, Hjort N, Gude MF. et al. A multicentre, randomised, sham-controlled trial on REmote iSchemic conditioning In patients with acute STroke (RESIST) - Rationale and study design. Eur Stroke J 2020; 5 (01) 94-101
    CrossrefPubMedGoogle Scholar